| South African Journal of Obstetrics and Gynaecology | |
| Hemoglobin level as the prognostic factor for patients with carcinoma cervix receiving radiation therapy | |
| Vinay Sharma1  uzma Majeed1  Ranjan Sur2  Bernard Donde2  | |
| [1] Johannesburg Hospital,University of witwatersrand;Johannesburg Hospital,University of Witwatersrand | |
| 关键词: Laparoscopy; Hysterectomy; Fibroids; | |
| DOI : | |
| 学科分类:农业科学(综合) | |
| 来源: South African Medical Association | |
PDF
|
|
【 摘 要 】
AbstractObjective: The primary objective was to assess the effect of pretreatment and mid treatment haemoglobin (Hb) level on local control, pelvic disease free and overall disease free survival. Material and MethodsSeventy-two patients with Carcinoma Cervix referred for radiation therapy between January and December 2002 were entered into this prospective study. Forty-three (59%) patients had stage II disease and 29 (41%) had stage III disease. Hb levels were checked before starting treatmentand in the middle of treatment. The mean Hb levels at the start and mid treatment were 12.8gm /dl and 12.1 gm/dl, respectively. Results Thirteen patients had treatment failures (pelvic 9, distant 3 and 1 pelvic and distant). Patients with mid treatment Hb levels of ≥12gm/dl had significantly lower pelvic failures (p=0.05) as well as overall failures (0.03) in comparison to patients with Hb levels of < 12gm/dl. The patients with mid treatment Hb level ≥ 12gm/dl had 5-year pelvic disease free survivaland overall disease free survival of 83%and 81% as compared to 66%and 58% for patients with Hb <12gm/dl (p=0.04 and p=0.02). The 5-year pelvic disease free survival for stage II was 89% compared with 45% for stage III (p=0.006). Conclusion A mid treatment Hb level of ≥12gm/dl had significantly higher pelvic control and 5-year pelvic disease free survival as well as overall survival. The stage of disease was an independent prognostic factor.
【 授权许可】
Unknown
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO201912010161031ZK.pdf | 247KB |
PDF